碧迪医疗(BDX)在周四盘前大跌5.29%,公司2024年第四财季业绩低于市场预期,引发市场担忧。
公司报告显示,碧迪医疗第四财季每股收益仅为1.04美元,远低于华尔街分析师预期的2.98美元。尽管公司这一季度营收和调整后每股收益均超出预期,但实际每股收益的疲软表现令投资者失望。
业内人士分析认为,碧迪医疗的财报数据令人担心,公司的业务前景和盈利能力面临一定压力。不过,给予该公司"买入"评级的分析师仍占多数,中期目标价为275美元左右。投资者正在密切关注碧迪医疗下一步的动向。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.